Therapeutic efficacy of recombinant human growth hormone in children with different etiologies of dwarfism from a pharmacoeconomic point of view.

MLA

Ma, Yanxia, et al. “Therapeutic Efficacy of Recombinant Human Growth Hormone in Children with Different Etiologies of Dwarfism from a Pharmacoeconomic Point of View.” Medicine, vol. 103, no. 25, June 2024, p. e38350. EBSCOhost, https://doi.org/10.1097/MD.0000000000038350.

APA

Ma, Y., Sheng, J., Wang, L., Zhang, Y., & Liu, L. (2024). Therapeutic efficacy of recombinant human growth hormone in children with different etiologies of dwarfism from a pharmacoeconomic point of view. Medicine, 103(25), e38350. https://doi.org/10.1097/MD.0000000000038350

Chicago

Ma, Yanxia, Jianping Sheng, Lijie Wang, Yanan Zhang, and Lin Liu. 2024. “Therapeutic Efficacy of Recombinant Human Growth Hormone in Children with Different Etiologies of Dwarfism from a Pharmacoeconomic Point of View.” Medicine 103 (25): e38350. doi:10.1097/MD.0000000000038350.